Phytochemicals in the prevention of lung cancer induced by tobacco carcinogens

Alcohol, Tobacco and Cancer

Volumn , Issue , 2006, Pages 268-287

  Chung, Fung Lung ^a   Mi, Lixin ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957268885     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1159/000095078     Document Type: Chapter

References (123)

1. Yang L, Parkin DM, Ferlay J, Li L, Chen Y: Estimates of cancer incidence in China for 2000 andprojections for 2005. Cancer Epidemiol Biomarkers Prev 2005;14:243-250.
2. Parkin DM, Bray F, Ferlay J, Pisani P: Global Cancer Statistics, 2002, Pisani, CA. Cancer J Clin2005;55:74-108.
3. Spira A, Ettiger D: Multidisciplinary management of lung cancer. N Eng J Med 2004;350:379-392.
4. Mendez D, Warner KE: Adult cigarette smoking prevalence: declining as expected (not asdesired). Am J Public Health 2004;94:251-252.
5. Institute of Medicine, Committee to Assess the Science Base for Tobacco Harm Reduction, andBoard on Health Promotion and Disease Prevention: Clearing the Smoke: Assessing the ScienceBase for Tobacco Harm Reduction. National Academy Press, Washington, DC, 2001.
6. Greenwald P: Beta-carotene and lung cancer: a lesson for future chemoprevention investigations?J Natl Cancer Inst 2003;95:E1.
7. Hecht SS: Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst 1999;91:1194-1210.
8. Hecht SS: Cigarette smoking and lung cancer: chemical mechanisms and approaches to preven-tion. Lancet Oncol 2002;3:461-469.
9. Denissenko MF, Pao A, Tang M, Pfeifer GP: Preferential formation of benzo[a]pyrene adducts atlung cancer mutational hotspots in P53. Science 1996;274:430-432.
10. Hecht SS, Morse MA, Amin S, Stoner GD, Jordan KG, Choi C-I, Chung F-L: Rapid single dosemodel for lung tumor induction in A/J mice by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanoneand the effect of diet. Carcinogenesis 1989;10:1901-1904.
11. Ross JA, Nelson GB, Wilson KH, Rabinowitz JR, Galati A, Stoner GD, Nesnow S, Mass MJ:Adenomas induced by polycyclic aromatic hydrocarbons in strain A/J mouse lung correlate withtime-integrated DNA adduct levels. Cancer Res1995;55:1039-1044.
12. Hoffmann D, Rivenson A, Amin S, Hecht SS: Dose-response study of the carcinogenicity oftobacco-specific N-nitrosamines in F344 rats. J Cancer Res Clin Oncol 1984;108:81-86.
13. Shimkin MB, Stoner GD: Lung tumors in mice: application to carcinogenesis bioassay. AdvCancer Res 1975;21:1-58.
14. Rehm S, Takahashi M, Ward JM, Singh G, Katyal SL, Henneman JR: Immunohisto-chemicaldemonstration of Clara cell antigen in lung tumors of bronchiolar origin induced by N-nitrosodiethylamine in Syrian golden hamsters. Am J Pathol 1989;134:79-87.
15. Schuller HM, Witschi HP, Nylen E, Joshi PA, Correa E, Becker KL: Pathobiology of lung tumorsinduced in hamsters by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and the modulatingeffect of hyperoxia. Cancer Res 1990;50:1960-1965.
16. Wang Y, Zhang Z, Kastens E, Lubet RA, You M: Mice with alterations in both p53 and Ink4a/Arfdisplay a striking increase in lung tumor multiplicity and progression: differential chemopreven-tive effect of budesonide in wild-type and mutant A/J mice. Cancer Res 2003;63:4389-4395.
17. Witschi H: A/J mouse as a model for lung tumorigenesis caused by tobacco smoke: strengths andweaknesses. Exp Lung Res 2005;31:3-18.
18. Mauderly JL, Gigliotti AP, Barr EB, Bechtold WE, Belinsky SA, Hahn FF, Hobbs CA, March TH,Seilkop SK, Finch FL: Chronic inhalation exposure to mainstream cigarette smoke increases lungand nasal tumor incidence in rats. Toxicol Sci 2004;81:280-292.
19. Hutt JA, Vuillemenot BR, Barr EB, Grimes MJ, Hahn FF, Hobbs CH, March TH, Gigliotti AP,Seilkop SK, Finch GL, Mauderly JL, Belinsky SA: Life-span inhalation exposure to mainstreamcigarette smoke induces lung cancer in B6C3F1 mice through genetic and epigenetic pathways.Carcinogenesis 2005;26:1999-2009.
20. Potter JD: Cancer prevention: epidemiology and experiment. Cancer Lett 1997;114:7-9.
21. Wattenberg LW: Inhibition of carcinogenic effects of polycyclic hydrocarbons by benzl isothio-cyanate and related compounds. J Natl Cancer Inst 1977;58:395-398.
22. Chung F-L, Juchatz A, Vitarius J, Hecht SS: Effects of dietary compounds on α- hydroxylationof N-nitrosopyrrolidine and N'-nitrosonornicotine in rat target tissues. Cancer Res 1984;44:2924-2928.
23. 6-methylguanine formation, and metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in A/J mouse lung. Cancer Res 1989;49:2894-2897.
24. Morse MA, Wang C-X, Stoner GD, Mandal S, Conran PB, Amin SG, Hecht SS, Chung F-L:Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced DNA adduct formationand tumorigenicity in the lung of F344 rats by dietary phenethyl isothiocyanate. Cancer Res1989;49:549-553.
25. Jiao D, Eklind KI, Choi C-I, Desai DH, Amin SG, Chung F-L: Structure-activity relationships ofisothiocyanates as mechanism-based inhibitors of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis in A/J mice. Cancer Res 1994;54:4327-4333.
26. Zhang Y, Talalay P, Cho CG, Posner GH: A major inducer of anticarcinogenic protective enzymesfrom broccoli: isolation and elucidation of structure. Proc Natl Acad Sci 1992;89:2399-2403.
27. Zhang Y, Kensler TW, Cho CG, Ponser GH, Talalay P: Anticarcinogenic activities of sulforaphaneand structurally related synthetic norbornyl isothiocyanates. Proc Natl Acad Sci 1994;91:3147-3150.
28. Fahey JW, Haristoy X, Dolan PM, Kensler TW, Scholtus I, Stephenson KK, Talalay P, Lozniewski A:Sulforaphane inhibits extracellular, intracellular, and antibiotic-resistant strains of Helicobacterpylori and prevents benzo[a]pyrene-induced stomach tumors. Proc Natl Acad Sci 2002;99:7610-7615.
29. Dinkova-Kostova AT, Jenkins SN, Fahey JW, Ye L, Wehage SL, Liby KT, Stephenson KK, Wade KL,Talalay P: Protection against UV-light-induced skin carcinogenesis in SKH-1 high-risk mice bysulforaphane-containing broccoli sprout extracts. Cancer Lett 2005; [epub ahead of print].
30. Yang Y-M, Conaway CC, Chiao JW, Wang C-X, Amin S, Whysner J, Dai W, Reinhardt J, Chung F-L:Inhibition of benzo(a)pyrene-induced lung tumorigenesis in A/J mice by dietary N-acetylcysteine conjugates of benzyl and phenethyl isothiocyanates during the post-initiation phase is associatedwith activation of MAP kinases and p53 activity and induction of apoptosis. Cancer Res 2002;62:2-7.
31. Conaway CC, Wang C-X, Pittman B, Yang Y-M, Schwartz JE, Tian D, McIntee EJ, Hecht SS,Chung F.-L: Phenethyl isothiocyanate and sulforaphane and their N-acetylcysteine conjugatesinhibit malignant progression of lung adenomas induced by obacco carcinogens in A/J mice.Cancer Res 2005;65:8548-8557.
32. Lin JM, Amin S, Trushin N, Hecht SS: Effects of isothiocyanates on tumorigenesis bybenzo[a]pyrene in murine tumor models. Cancer Lett 1993;74:151-159.
33. Wattenberg LW: Inhibitory effects of benzyl isothiocyanate administered shortly beforediethylnitrosamine or benzo[a]pyrene on pulmonary and forestomach neoplasia in A/J mice.Carcinogenesis 1987;8:1971-1973.
34. Chung FL, Kelloff G, Steele V, Pittman B, Zang E, Jiao D, Rigotty J, Choi C-I, Rivenson A:Chemopreventive efficacy of arylalkyl isothiocyanates and N-acetylcysteine for lung tumorigene-sis in Fischer rats. Cancer Res 1996;56:772-778.
35. Morse MA, Eklind KI, Amin SG, Hecht SS, Chung F-L: Effects of alkyl chain length on the inhi-bition of NNK-induced lung neoplasia in A/J mice by arylalkyl isothiocyanates. Carcinogenesis1989;10:1757-1759.
36. Morse MA, Eklind KI, Hecht SS, Jordan KG, Choi C-I, Desai DH, Amin SG, Chung F-L:Structure-activity relationships for inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanonelung tumorigenesis by arylalkyl isothiocyanates in A/J mice. Cancer Res 1991;51:1846-1850.
37. Matzinger SA, Crist KA, Stoner GD, Anderson MW, Pereira MA, Steele VE, Kelloff GJ, LubetRA, You M: K-ras mutations in lung tumors from A/J and A/J × TSG-p53 F1 mice treated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and phenethyl isothiocyanate. Carcinogenesis1995;16:2487-2492.
38. El-Bayoumy K, Upadhyaya P, Desai DH, Amin S, Hoffmann D, Wynder EL: Effects of 1,4-phenylenebis(methylene)selenocyanate, phenethyl isothiocyanate, indole-3-carbinol, and d-limonene individually and in combination on the tumorigenicity of the tobacco-specificnitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in A/J mouse lung. Anticancer Res1996;16:2709-2712.
39. Jiao D, Smith TJ, Yang CS, Pittman B, Desai D, Amin S, Chung F-L: Chemopreventive activity ofthiol conjugates of isothiocyanates for lung tumorigenesis. Carcinogenesis 1997;18:2143-2147.
40. Witschi H, Espiritu I, Yu M, Willits NH: The effects of phenethyl isothiocyanate, N-acetylcysteineand green tea on tobacco smoke-induced lung tumors in strain A/J mice. Carcinogenesis1998;19:1789-1794.
41. Nishikawa A, Furukawa F, Ikezaki S, Tanakamaru Z, Chung F-L, Takahashi M, Hayashi Y:Chemopreventive effects of 3-phenylpropyl isothiocyanate on hamster lung tumorigenesis initi-ated with N-nitrosobis(2-oxopropyl)amine. Jpn J Cancer Res 1996;87:122-126.
42. Milner JA, MCDonald SS, Anderson DE, Greenwald P: Molecular targets for nutrients involvedwith cancer prevention. Nutr Cancer 2001;41:1-16.
43. Ashendel CL: Diet signal transduction and carcinogenesis. J Nutr 1995;125:686S-691S.
44. Kong AN, Yu R, Hebbar V, Chen C, Owuor E, Hu R, Ee R, Mandlekar S: Signal transductionevents elicited by cancer prevention compounds. Mutat Res 2001;480-481:231-241.
45. Keum YS, Jeong WS, Kong AN: Chemoprevention by isothiocyanates and their underlying mole-cular signaling mechanisms. Mutat Res 2004;555:191-202.
46. Dinkova-Kostova AT, Holtzdaw WD, Cole RN, Itoh K, Wakabayashi N, Katoh Y, Yamamoto M, Talalay P:Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase a2enzymes that protect against carcinogens and oxidants: Proc Natl Acad Sci 2002;99:11908-11913.
47. Yu R, Chen C, Mo YY, Hebbar V, Owuor ED, Tan TH, Kong AN: Activation of mitogen-activatedprotein kinase pathways induces antioxidant response element-mediated gene expression via aNrf2-dependent mechanism. J Biol Chem 2000;275:39907-39913.
48. Keum YS, Owuor ED, Kim BR, Hu R, Kong AN: Involvement of Nrf2 and JNK1 in the activationof antioxidant responsive element (ARE) by chemopreventive agent phenethyl isothiocyanate(PEITC). Pharm Res 2003;20:1351-1356.
49. Lee M, Hanson JM, Chu WA, Johnson JA: Phosphatidylinositol 3-kinase, not extracellular signal-regulated kinase, regulates activation of the antioxidant-responsive element in IMR-32 humanneuroblastoma cells. J Biol Chem 2001;276:20011-20016.
50. Kang KW, Lee SJ, Park JW, Kim SG: Phosphatidylinositol 3-kinase regulates nuclear transloca-tion of NF-E2-related factor 2 through actin rearrangement in response to oxidative stress. MolPharmacol 2002;62:1001-1010.
51. Chen YR, Wang W, Kong AN, Tan TH: Molecular mechanisms of c-Jun N-terminal kinase-mediatedapoptosis induced by anticarcinogenic isothiocyanates. J Biol Chem 1998;273:1769-1775.
52. Chen YR, Han J, Kori R, Kong AN, Tan TH: Phenylethyl isothiocyanate induces apoptotic signal-ing via suppressing phosphatase activity against c-Jun N-terminal kinase. J Biol Chem 2002;277:39334-39342.
53. Chaudhary PM, Eby MT, Jasmin A, Hood L: Activation of the c-Jun N-terminal kinase/stress-activated protein kinase pathway by overexpression of caspase-8 and its homologs. J Biol Chem1999;274:19211-19219.
54. Yu R, Mandlekar S, Harvey KJ, Ucker DS, Kong AN: Chemopreventive isothiocyanates induceapoptosis and caspase-3-like protease activity. Cancer Res 1998;58:402-408.
55. Xu K, Thornalley PJ: Studies on the mechanism of the inhibition of human leukaemia cell growthby dietary isothiocyanates and their cysteine adducts in vitro. Biochem Pharmacol 2000;60:221-231.
56. Xiao D, Singh SV: Phenethyl isothiocyanate-induced apoptosis in p53-deficient PC-3 humanprostate cancer cell line is mediated by extracellular signal-regulated kinases. Cancer Res 2002;62:3615-3619.
57. Huang C, Ma WY, Li J, Hecht SS, Dong Z: Essential role of p53 in phenethyl isothiocyanate-induced apoptosis. Cancer Res 1998;58:4102-4106.
58. Kuang YF, Chen YH: Induction of apoptosis in a non-small cell human lung cancer cell line byisothiocyanates is associated with P53 and P21. Food Chem Toxicol 2004;42:1711-1718.
59. Yang Y-M, Jhanwar-Uniyal M, Schwartz J, Conaway CC, Halicka HD, Traganos F, Chung F-L: N-acetylcysteine conjugate of phenethyl isothiocyanate enhances apoptosis in growth-stimulatedhuman lung cells. Cancer Res 2005;65:8538-8547.
60. London SJ, Yuan J-M, Chung FL, Gao Y-T, Coetzee GA, Ross RK, Yu MC: Isothiocyanates,glutathione S-transferase M1 and T1 polymorphisms and lung cancer risk: a prospective study ofmen in Shanghai, China. Lancet 2000;356:724-729.
61. Spitz MR, Duphorne CM, Detry MA, Pillow PC, Amos CI, Lei L, de Andrade M, Gu X, HongWK, Wu X: Dietary intake of ITC: evidence of a joint effect with GST polymorphisms in lungcancer. Cancer Epidemiol Biomarker Prev 2000;9:1017-1020.
62. Zhao B, Seow A, Lee EJ, Poh WT, Teh M, Eng P, Wang YT, Tan WC, Yu MC, Lee HP: Dietary ITC,GSTM1, t1, polymorphisms and lung cancer risk among Chinese women in Singapore. CancerEpidemiol Biomarker Prev 2001;10:1063-1067.
63. Fowke JH, Chung FL, Jin F, Qi D, Cai Q, Conaway C, Cheng JR, Shu XO, Gao YT, Zheng W:Urinary ITC levels, Brassica, and human breast cancer. Cancer Res 2003;63:3980-3986.
64. Lin DX, Tang YM, Peng Q, Lu SX, Ambrosone CB, Kadlubar FF: GST null genotypes, broccoliand lower prevalence of colorectal adenomas. Cancer Epidemiol Biomarker Prev 1998;7:1013-1018.
65. Seow A, Yuan JM, Sun CL, Van Den Berg D, Lee HP, Yu MC: Dietary ITCs, GST polymorphismsand colorectal cancer risk in Singapore Chinese health study. Carcinogenesis 2002;23:2055-2061.
66. Shukla Y, Taneja P: Anticarcinogenic effect of black tea on pulmonary tumors in Swiss albinomice. Cancer Lett 2002;176:137-141.
67. Yang CS, Yang GY, Landau JM, Kim S, Liao J: Tea and tea polyphenols inhibit cell hyperprolifer-ation, lung tumorigenesis, and tumor progression. Exp Lung Res 1998;24:629-639.
68. Chung FL, Wang M, Rivenson A, Iatropoulos MJ, Reinhardt JC, Pittman B, Ho CT, Amin SG:Inhibition of lung carcinogenesis by black tea in Fischer rats treated with a tobacco-specific car-cinogen: caffeine as an important constituent. Cancer Res 1998;58:4096-4101.
69. Cao J, Xu Y, Chen J, Klaunig JE: Chemopreventive effects of green and black tea on pulmonaryand hepatic carcinogenesis. Fundam Appl Toxicol 1996;29:244-250.
70. Katiyar SK, Agarwal R, Mukhtar H: Protective effects of green tea polyphenols administered byoral intubation against chemical carcinogen-induced forestomach and pulmonary neoplasia in A/Jmice. Cancer Lett 1993;73:167-172.
71. Katiyar SK, Agarwal R, Zaim MT, Mukhtar H: Protection against N-nitrosodiethylamine andbenzo[a]pyrene-induced forestomach and lung tumorigenesis in A/J mice by green tea. Carcinogenesis1993;14:849-855.
72. Wang ZY, Agarwal R, Khan WA, Mukhtar H: Protection against benzo[a]pyrene- and N-nitrosodiethylamine-induced lung and forestomach tumorigenesis in A/J mice by water extractsof green tea and licorice. Carcinogenesis 1992;13:1491-1494.
73. Wang ZY, Hong JY, Huang MT, Reuhl KR, Conney AH, Yang CS: Inhibition of N-nitrosodiethylamine-and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced tumorigenesis in A/J mice by greentea and black tea. Cancer Res 1992;52:1943-1947.
74. Liao J, Yang GY, Park ES, Meng X, Sun Y, Jia D, Seril DN, Yang CS: Inhibition of lung carcino-genesis and effects on angiogenesis and apoptosis in A/J mice by oral administration of green tea.Nutr Cancer 2004;48:44-53.
75. Schuller HM, Porter B, Riechert A, Walker K, Schmoyer R: Neuroendocrine lung carcinogenesisin hamsters is inhibited by green tea or theophylline while the development of adenocarcinomas ispromoted: implications for chemoprevention in smokers. Lung Cancer 2004;45:11-18.
76. Xu Y, Ho CT, Amin SG, Han C, Chung FL: Inhibition of tobacco-specific nitrosamine-inducedlung tumorigenesis in A/J mice by green tea and its major polyphenol as antioxidants. Cancer Res1992;52:3875-3879.
77. Shi S, Wang ZY, Smith TJ, Hong J-Y, Chen W-F, Ho C-T, Yang CS: Effects of green tea and blacktea on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone bioactivation, DNA methylation and lungtumorigenesis in A/J mice. Cancer Res 1994;54:4641-4647.
78. Yang G-Y, Wang ZY, Kim S, Liao J, Seril D, Chen X, Smith TJ, Yang CS: Characterization ofearlypulmonary hyperproliferation, tumor progression and their inhibition by black tea in a 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis model with A/J mice.Cancer Res 1997;57:1889-1894.
79. Luo D, Li Y: Preventive effect of green tea on MNNG-induced lung cancers and precancerouslesions in LACA mice. Hua Xi Yi Ke Da Xue Xue Bao 1992;23:433-437.
80. Luo SQ, Liu XZ, Wang CJ: Inhibitory effect of green tea extract on the carcinogenesis induced byasbestos plus benzo(a)pyrene in rat. Biomed Environ Sci 1995;8:54-58.
81. Landau J, Wang Z-Y, Yang G-Y, Ding W, Yang C-S: Inhibition of spontaneous formation of lung tumorsand rhabdomyosarcomas in A/J mice by black and green tea. Carcinogenesis 1998;19:501-507.
82. Yang CS, Maliakal P, Meng X: Inhibition of carcinogenesis by tea. Annu Rev Pharmacol Toxicol2002;42:25-54.
83. Paschka AG, Butler R, Young CY: Induction of apoptosis in prostate cancer cell lines by the greentea component, (-)-epigallocatechin-3-gallate. Cancer Lett 1998;130:1-7.
84. Ahn WS, Huh SW, Bae SM, Lee IP, Lee JM, Namkoong SE, Kim CK, Sin JI: A major constituentof green tea, EGCG, inhibits the growth of a human cervical cancer cell line, CaSki cells, throughapoptosis, G(1) arrest, and regulation of gene expression DNA. Cell Biol 2003;22:217-224.
85. Isemura M, Saeki K, Kimura T, Hayakawa S, Minami T, Sazuka M: Tea catechins and relatedpolyphenols as anti-cancer agents. Biofactors 2000;13:81-85.
86. Naasani I, Oh-Hashi F, Oh-Hara T, Fen WY, Johnston J, Chan K, Tsuruo T: Blocking telomeraseby dietary polyphenols is a major mechanism for limiting the growth of human cancer cells invitro and in vivo. Cancer Res 2003;63:824-830.
87. Chung JY, Huang C, Meng X, Dong Z, Yang CS: Inhibition of activator protein 1 activity and cellgrowth by purified green tea and black tea polyphenols in H-ras-transformed cells: structure-activity relationship and mechanisms involved. Cancer Res 1999;59:4610-4617.
88. Chung JY, Park JO, Phyu H, Dong Z, Yang CS: Mechanisms of inhibition of the Ras-MAP kinasesignaling pathway in 30.7b Ras 12 cells by tea polyphenols (-)-epigallocatechin-3-gallate andtheaflavin-3,3́-digallate. FASEB J 2001;15:2022-2024.
89. Lin JK, Liang YC, Lin-Shiau SY: Cancer chemoprevention by tea polyphenols through mitoticsignal transduction blockade. Biochem Pharmacol 1999;58:911-915.
90. Liang YC, Chen YC, Lin YL, Lin-Shiau SY, Ho CT, Lin JK: Suppression of extracellular signalsand cell proliferation by the black tea polyphenol, theaflavin-3,3'-digallate. Carcinogenesis1999;20:733-736.
91. Cao Y, Cao R: Angiogenesis inhibited by drinking tea. Nature 1999;398:381.
92. Islam S, Islam N, Kermode T, Johnstone B, Mukhtar H, Moskowitz RW, Goldberg VM, Malemud CJ,Haqqi TM: Involvement of caspase-3 in epigallocatechin-3-gallate-mediated apoptosis of humanchondrosarcoma cells. Biochem Biophys Res Commun 2000;270:793-797.
93. Rodriguez SK, Guo W, Liu L, Band MA, Paulson EK, Meydani M: Green tea catechin, epigallo-catechin-3-gallate, inhibits vascular endothelial growth factor angiogenic signaling by disruptingthe formation of a receptor complex. Int J Cancer 2005; [epub ahead of print].
94. Lu H, Meng X, Yang CS: Enzymology of methylation of tea catechins and inhibition of catechol-O-methyltransferase by (-)-epigallocatechin gallate. Drug Metab Dispos 2003;31:572-579.
95. Lu H, Meng X, Li C, Sang S, Patten C, Sheng S, Hong J, Bai N, Winnik B, Ho CT, Yang CS:Glucuronides of tea catechins: enzymology of biosynthesis and biological activities. Drug MetabDispos 2003;31:452-461.
96. Lu H: Mechanistic studies on the phase II metabolism and absorption of tea catechins. Toxicology2002; Rutgers The State University of New Jersey, New Brunswick, 2002.
97. Meselhy MR, Nakamura N, Hattori M: Biotransformation of (-)-epicatechin 3-O-gallate byhuman intestinal bacteria. Chem Pharm Bull (Tokyo) 1997;45:888-893.
98. Hong J, Lu H, Meng X, Ryu JH, Hara Y, Yang CS: Stability, cellular uptake, biotransformation,and efflux of tea polyphenol (-)-epigallocatechin-3-gallate in HT-29 human colon adenocarcinomacells. Cancer Res 2002;62:7241-7246.
99. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, Lyon: Coffee, tea,mate, methylxanthines, and methylglyoxal. IARC Monogr Eval Carcinog Risks Hum 1991;51:1-530.
100. Yang CS, Wang ZY: Tea and cancer. J Natl Cancer Inst 1993;85:1038-1049.
101. Bonner MR, Rothman N, Mumford JL, He X, Shen M, Welch R, Yeager M, Chanock S, Caporaso N,Lan Q: Green tea consumption, genetic susceptibility, PAH-rich smoky coal, and the risk of lungcancer. Mutat Res 2005;582:53-60.
102. Nagano J, Kono S, Preston DL, Mabuchi K: A prospective study of green tea consumption andcancer incidence, Hiroshima and Nagasaki (Japan). Cancer Causes Control 2001;12:501-508.
103. Mendilaharsu M, De Stefani E, Deneo-Pellegrini H, Carzoglio JC, Ronco A: Consumption of teaand coffee and the risk of lung cancer in cigarette-smoking men: a case-control study in Uruguay.Lung Cancer 1998;19:101-107.
104. Hakim IA, Harris RB, Chow HH, Dean M, Brown S, Ali IU: Effect of a 4-month tea interventionon oxidative DNA damage among heavy smokers: role of glutathione S-transferase genotypes.Cancer Epidemiol Biomarkers Prev 2004;13:242-249.
105. Steele VE, Kelloff GJ: Development of cancer chemopreventive drugs based on mechanisticapproaches. Mutat Res 2005;591:16-23.
106. Wattenberg LW, Coccia JB: Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone car-cinogenesis in mice by D-limonene and citrus fruit oils. Carcinogenesis 1991;12:115-117.
107. Khanduja KL, Gandhi RK, Pathania V, Syal N: Prevention of N-nitrosodiethylamine-induced lungtumorigenesis by ellagic acid and quercetin in mice. Food Chem Toxicol 1999;37:313-318.
108. Narayanan BA, Geoffroy O, Willingham MC, Re GG, Nixon DW: P53/p21(WAF1/CIP1) expres-sion and its possible role in G1 arrest and apoptosis in ellagic acid treated cancer cells. Cancer Lett1999;136:215-221.
109. Berge G, Ovrebo S, Eilertsen E, Haugen A, Mollerup S: Analysis of resveratrol as a lung cancerchemopreventive agent in A/J mice exposed to benzo[a]pyrene. Br J Cancer 2004;91:1380-1383.
110. Lee HY: Molecular mechanisms of degueline-induced apoptosis in transformed human bronchialepithelial cells. Biochem Parmacol 2004;68:1119-1124.
111. Lee HY, Oh SH, Woo JK, Kim WY, Van Pelt CS, Price RE, Cody D, Tran H, Pezzuto JM, Moriarty RM,Hong WK: Chemopreventive effects of deguelin, a novel Akt inhibitor, on tobacco-induced lungtumorigenesis. J Natl Cancer Inst 2005;97:1695-1699.
112. Chun K-H, Kosmeder JW 2nd, Sun S, Pezzuto JM, Lotan R, Hong WK, Lee HY: Effects ofdeguelin on the phosphatidylinositol 3-kinase/Akt pathway and apoptosis in premalignant humanbronchial epithelial cells. J Natl Cancer Inst 2003;95:291-302.
113. Selvendiran K, Senthilnathan P, Magesh V, Sakthisekaran D: Modulatory effect of Piperine onmitochondrial antioxidant system in Benzo(a)pyrene-induced experimental lung carcinogenesis.Phytomedicine 2004;11:85-89.
114. Srivastava SK, Hu X, Xia H, Zaren HA, Chatterjee ML, Agarwal R, Singh SV: Mechanism of dif-ferential efficacy of garlic organosulfides in preventing benzo(a)pyrene-induced cancer in mice.Cancer Lett 1997;118:61-67.
115. Sakamoto K, Lawson LD, Milner JA: Allyl sulfides from garlic suppress the in vitro proliferationof human A549 lung tumor cells. Nutr Cancer 1997;29:152-156.
116. Wu XJ, Kassie F, Mersch-Sundermann V: The role of reactive oxygen species (ROS) productionon diallyl disulfide (DADS) induced apoptosis and cell cycle arrest in human A549 lung carci-noma cells. Mutat Res 2005;579:115-124.
117. Li Y, Ahmed F, Ali S, Philip PA, Kucuk O, Sarkar FH: Inactivation of nuclear factor kappaB by soyisoflavone genistein contributes to increased apoptosis induced by chemotherapeutic agents inhuman cancer cells. Cancer Res 2005;65:6934-6942.
118. Seike N, Wanibuchi H, Morimura K, Wei M, Nishikawa T, Hirata K, Yoshikawa J, Fukushima S:Enhancement of lung carcinogenesis by nonylphenol and geinstein in a F344 rat multiorgan car-cinogenesis model. Cancer Lett 2003;192:25-36.
119. Morse MA, LaGreca SD, Amin SG, Chung F-L: Effects of indole-3-carbinol on lung tumorigene-sis and DNA methylation induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK),and on the metabolism and disposition of NNK in A/J mice. Cancer Res 1990;50:2613-2617.
120. Yamagishi M, Natsume M, Osakabe N, Okazaki K, Furukawa F, Imazawa T, Nishikawa A, Hirose M:Chemoprevention of lung carcinogenesis by cacao liquor proanthocyanidins in a male rat multi-organcarcinogenesis model. Cancer Lett 2003;191:49-57.
121. Kim DJ, Takasuka N, Nishino H, Tsuda H: Chemoprevention of lung cancer by lycopene. Biofactors2000;13:95-102.
122. Liu C, Lian F, Smith DE, Russell RM, Wang XD: Lycopene supplementation inhibits lung squa-mous metaplasia and induces apoptosis via up-regulating insulin-like growth factor-binding pro-tein 3 in cigarette smoke-exposed ferrets. Cancer Res 2003;63:3138-3144.
123. Schabath MB, Hernandez LM, Wu X, Pillow PC, Spitz MR: Dietary phytoestrogens and lung can-cer risk. JAMA 2005;294:1550-1551.